aTouchAway
Cardiovascular Risk Monitoring After Stem Cell Transplant: 2020 Feasibility Study
Research context (2020): This archived article describes a four-week feasibility and acceptability study involving 18 hematopoietic cell transplantation survivors, not a controlled trial showing reduced cardiovascular events…
Read article →